Skip to main content
. Author manuscript; available in PMC: 2021 Jul 1.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2020 Mar 7;107(3):487–498. doi: 10.1016/j.ijrobp.2020.02.031

Table 1.

Patient characteristics

Characteristics All patients Cohort 1 Cohort 2
Median age (range), y 51.5 (26-60) 52 (29-60) 44 (26-50)
Race
 White 6 5 1
 Black 2 1 1
 Other 2 1 1
Ethnicity
 Hispanic or Latino 3 2 1
 Non-Hispanic or Latino 7 5 2
Median BMI (range), kg/m2 26.9 (18.7-47.9) 24.3 (18.7-47.9) 32.1 (27.0-37.3)
FIGO clinical stage
 IB1 3 2 1
 IB2 2 2 0
 IIB 2 2 0
 IIIB 2 1 1
 IVA 1 0 1
Lymph node status
 Positive 4 2 2
 Negative 5 4 1
 Missing 1 1 0
Cell type
 Squamous 4 3 1
 Adenocarcinoma 6 4 2
Tumor grade
 1 4 4 0
 2 3 2 1
 3 3 1 2
Median tumor diameter, (range), cm 5.4 (3.8-6.4) 5.6 (3.8-6.4) 5.2 (4.5-6.0)
HPV status
 HPV16 7 5 2
 HPV18 3 2 1
 HPV16 and HPV18 0 0 0

Abbreviations: BMI = body mass index; FIGO = Federation of Gynecology and Obstetrics; HPV = human papillomavirus.